Sr. Associate Manager / Lead, GMQO at Eli Lilly and Company

Bengaluru, Karnataka, India

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Experience in quality systems, compliance, and clinical development support
  • Ability to contribute to development of procedures, tools, and documents
  • Knowledge of deviations, change controls, NTM, root cause analysis, and CAPA
  • Skills in risk assessments, audit planning, and quality plans
  • Capability to conduct self-inspections and drive improvements
  • Understanding of external party management (e.g., third-party organizations, partners)
  • Proficiency in monitoring compliance, metrics, trending, and process improvements
  • Experience in audits/inspections support (preparation, coordination, responses)
  • Partnership and consultation skills with business areas like Clinical Development

Responsibilities

  • Implement and manage quality systems, including development of procedures, tools, and documents
  • Recommend new or changes to quality system documents
  • Advise on training, interpretation, and application of requirements/standards
  • Handle deviations, change controls, NTM; ensure documentation, escalation, and completion
  • Consult on root cause analysis, CAPA review/approval
  • Provide input into risk assessments, audit planning, and quality plans
  • Complete self-inspections and drive actionable improvements
  • Ensure local implementation of quality systems and support external party management
  • Provide quality oversight for Clinical Development: monitor compliance, propose solutions, escalate issues
  • Implement regional/affiliate Quality Plans, monitor progress, provide updates
  • Seek process simplification/improvement and coordinate quality initiatives
  • Review metrics/trends, compile reports, analyze gaps, recommend actions
  • Monitor deviations, change controls, CAPA, audit responses
  • Support audits/inspections (preparation, coordination, back/front room, responses)
  • Ensure inspection readiness and completion of audit CAPAs
  • Partner with Clinical Development as point of consultation, strengthen quality controls, share learnings

Skills

Quality Systems
CAPA
Root Cause Analysis
Change Control
Deviations Management
Audit Support
Risk Assessment
Regulatory Compliance
Training Development

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI